-
1
Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
Published 2024-10-01Subjects: Get full text
Article -
2
Pasireotide: A new option for treatment of acromegaly
Published 2020-06-01Subjects: Get full text
Article -
3
Autozhel' v kontrole biokhimicheskikh markerovaktivnosti akromegalii: predstavlenieklinicheskogo sluchaya
Published 2010-12-01Subjects: Get full text
Article -
4
Adherence to somatostatin analog therapy for acromegaly
Published 2021-05-01Subjects: Get full text
Article -
5
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
Published 2021-05-01Subjects: Get full text
Article -
6
Loss of efficacy of pasireotide after its re-administration: is there a reason why?
Published 2016-12-01Subjects: Get full text
Article -
7
Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel®: A Case Report
Published 2014-09-01Subjects: Get full text
Article -
8
Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient
Published 2020-11-01Subjects: Get full text
Article -
9
-
10
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
Published 2017-08-01Subjects: Get full text
Article -
11
Transformation of a microprolactinoma into a mixed growth hormone and prolactin-secreting pituitary adenoma
Published 2012-01-01Subjects: Get full text
Article -
12
-
13
-
14
Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment
Published 2019-03-01Subjects: Get full text
Article -
15
Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
Published 2017-04-01Subjects: Get full text
Article -
16
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs
Published 2021-04-01Subjects: Get full text
Article -
17
-
18
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
Published 2019-03-01Subjects: Get full text
Article -
19
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism
Published 2024-02-01Subjects: Get full text
Article -
20
AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients
Published 2019-04-01Subjects: Get full text
Article